Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Beyond gastric applications, BPC-157 shows therapeutic potential for lesions throughout the gastrointestinal tract, including esophagus, duodenum, small intestine, colon, liver, and pancreas
Consult healthcare professionals for guidance and to address any potential health and safety concerns
In studies involving inflammatory bowel disease (IBD), the peptide has been shown to mitigate intestinal inflammation, reduce lesion size, and promote the regeneration of the epithelial lining
Schedule your consultation today.
It instead points research teams toward COA review, analytical testing, identity documentation, purity data, and lot-level traceability
US$ 21.49
US$ 28.82
US$ 21.02
US$ 24.26
US$ 26.67
